Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
acuity, aid, animal, arrangement, baseline, CHM, Choroideremia, CMC, CRF, Cystoid, delivery, duration, earned, Edema, expand, eyedrop, flat, formulated, formulation, Foundation, health, ideally, injection, intraocular, intravitreal, Lastly, lesser, low, Macular, medicine, Memorandum, midpoint, overactive, Posterior, potent, rare, released, removed, reset, restaffing, scientific, showed, simplified, staffing, Stargardt, suited, thought, treat, unallocated, unchanged, volume
Removed:
biochemistry, body, chain, clinically, coagulation, commercially, consolidation, consumption, cornea, Corneal, correction, developed, dose, Epithelial, factor, fourth, generation, GLP, healthcare, healthy, heightening, hematology, highest, histopathology, hydrate, immune, impacted, initiate, integrity, keratectomy, laboratory, laser, licensor, liver, maintenance, modulating, mortality, natural, newly, observed, ocular, ophthalmoscopy, OPRA, organ, overcome, Persistent, photorefractive, picomolar, POC, polymer, potency, PRK, procedure, protect, recovering, repeated, ROU, safety, seeking, side, supply, surface, surgery, surgical, test, tested, tolerability, topline, toxicity, uncertain, undergoing, unique, validated, weight
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view